These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7959355)

  • 1. Simplified prothrombin time standardization.
    Talstad I; Korsbrekke K
    Haemostasis; 1994; 24(1):4-13. PubMed ID: 7959355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prothrombin time standardization by correction of the Pivka inhibitor.
    Talstad I
    Haemostasis; 1996; 26(5):266-75. PubMed ID: 8894657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Why is the standardization of prothrombin time a problem?
    Talstad I
    Haemostasis; 2000; 30(5):258-67. PubMed ID: 11251333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simplified calibration of prothrombin time assays.
    Talstad I
    Haemostasis; 1994; 24(1):14-21. PubMed ID: 7959351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does the Pivka inhibitor interfere with the one-stage prothrombin time?
    Talstad I
    Haemostasis; 1985; 15(5):304-9. PubMed ID: 4076836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
    Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
    Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Accuracy and reliability of international normalized ratio (INR) in monitoring of warfarin--comparison in the sensitivity to extrinsic coagulation factors between PT (INR) and TT (INR)].
    Sakayori T; Naito S; Yoshida M; Kumano O; Kato N; Okuda M; Ieko M
    Rinsho Byori; 2010 Aug; 58(8):779-85. PubMed ID: 20860170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
    Samama MM; Martinoli JL; LeFlem L; Guinet C; Plu-Bureau G; Depasse F; Perzborn E
    Thromb Haemost; 2010 Apr; 103(4):815-25. PubMed ID: 20135059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation.
    Arnesen H; Smith P
    Thromb Res; 1991 Feb; 61(3):311-4. PubMed ID: 1822957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the use of commercial drug-specific calibrators for determining PT and APTT reagent sensitivity to dabigatran and rivaroxaban.
    Gosselin RC; Adcock D; Hawes EM; Francart SJ; Grant RP; Moll S
    Thromb Haemost; 2015 Jan; 113(1):77-84. PubMed ID: 25413383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
    Kagawa K; Fukutake K
    Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between CoaguChek S- and Owren-type prothrombin time assay for monitoring anticoagulant therapy.
    Jonsson M; Hillarp A; Svensson P
    Thromb Res; 2004; 114(2):83-9. PubMed ID: 15306149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Problems in the standardization of a prothrombin test (a review of literature)].
    Vladimirova SG; Tarasova LN
    Klin Lab Diagn; 2008 Oct; (10):51-4. PubMed ID: 19069448
    [No Abstract]   [Full Text] [Related]  

  • 15. Which coagulation factors interfere with the one-stage prothrombin time?
    Talstad I
    Haemostasis; 1993; 23(1):19-25. PubMed ID: 8477905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined antenatal vitamin K and phenobarbital therapy on umbilical blood coagulation studies in infants less than 34 weeks' gestation.
    Thorp JA; Caspers DR; Cohen GR; Zucker ML; Strope BD; McKenzie DR
    Obstet Gynecol; 1995 Dec; 86(6):982-9. PubMed ID: 7501353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prothrombin time and its standardization: a potentiality to introduce INR method in criteria for disseminated intravascular coagulation].
    Kagawa K; Fukutake K
    Rinsho Byori; 2002 Mar; 50(3):277-82. PubMed ID: 11985056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An analysis of the one-stage prothrombin time.
    Talstad I
    Haemostasis; 1985; 15(5):310-7. PubMed ID: 4076837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.